Fundraising Fox同源康医药 (TYK Medicines)
2 known investors
Find your way into 同源康医药 (TYK Medicines)
Sign up to see every warm intro you have to 同源康医药 (TYK Medicines)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 同源康医药 (TYK Medicines) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TYK Medicines (同源康) is a Chinese biopharmaceutical company focused on discovering and developing innovative small-molecule drugs, with a platform for designing and screening targeted-therapy compounds. Its pipeline includes EGFR-targeting treatments for non-small cell lung cancer and brain metastases.
Investors · 2
Frequently asked questions
- What does 同源康医药 (TYK Medicines) do?
- TYK Medicines (同源康) is a Chinese biopharmaceutical company focused on discovering and developing innovative small-molecule drugs, with a platform for designing and screening targeted-therapy compounds. Its pipeline includes EGFR-targeting treatments for non-small cell lung cancer and brain metastases.
- Who are 同源康医药 (TYK Medicines)'s investors?
- 同源康医药 (TYK Medicines)'s investors include Addor Capital, BioTrack Capital.